Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00110214
What this trial is testing

Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 1,050
Testing effectiveness (Phase 2)UnknownNCT00348998
What this trial is testing

Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Virginia Mason Hospital/Medical Center 18
Not applicableUnknownNCT00392535
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 3,216
Large-scale testing (Phase 3)Study completedNCT00316927
What this trial is testing

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
St. Bartholomew's Hospital 260
Testing effectiveness (Phase 2)Study completedNCT00466752
What this trial is testing

Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage II Prostate CancerStage III Prostate Cancer
University of Washington 5
Testing effectiveness (Phase 2)Study completedNCT00244998
What this trial is testing

Fulvestrant in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 20
Early research (Phase 1)Study completedNCT00482807
What this trial is testing

Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

Who this might be right for
Prostate Cancer
University of Nebraska 9
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Not applicableActive Not RecruitingNCT00769223
What this trial is testing

Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer

Who this might be right for
Prostate CancerRadiation Toxicity
University of California, San Francisco 3,561
Early research (Phase 1)Study completedNCT01912820
What this trial is testing

Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+4 more
Jonsson Comprehensive Cancer Center 32
Very early researchStudy completedNCT04976257
What this trial is testing

Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

Who this might be right for
Prostate AdenocarcinomaProstate CarcinomaStage IIC Prostate Cancer AJCC v8+7 more
Ryan Kohlbrenner, MD 5
Not applicableEnded earlyNCT00379119
What this trial is testing

Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 20
Early research (Phase 1)Study completedNCT00061867
What this trial is testing

Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Imunon
Testing effectiveness (Phase 2)Study completedNCT00246753
What this trial is testing

Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 29
Not applicableStudy completedNCT00003045
What this trial is testing

Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 38
Testing effectiveness (Phase 2)Ended earlyNCT01703065
What this trial is testing

Cabozantinib in Men With Castration-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateCastration-resistant Prostate CancerRecurrent Prostate Cancer+2 more
University of Washington 9
Large-scale testing (Phase 3)Looking for participantsNCT01492972
What this trial is testing

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Proton Collaborative Group 192
Testing effectiveness (Phase 2)WithdrawnNCT00244920
What this trial is testing

Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00002703
What this trial is testing

Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Proton Radiation Oncology Group 390
Large-scale testing (Phase 3)Study completedNCT00005044
What this trial is testing

Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,579
Next Page